(Q40384795)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

20 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Mechanistic analysis of the role of BLCA-4 in bladder cancer pathobiology (English)

1 reference

20 September 2017

Julie M Myers-Irvin

1

1 reference

20 September 2017

Thu-Suong Van Le

series ordinal

2

1 reference

20 September 2017

Robert H Getzenberg

series ordinal

3

1 reference

20 September 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

20 September 2017

1 reference

20 September 2017

volume

65

1 reference

20 September 2017

issue

16

1 reference

20 September 2017

page(s)

7145-7150

1 reference

Retraction: Mechanistic analysis of the role of BLCA-4 in bladder cancer pathobiology.

20 September 2017

is retracted by

0 references

cites work

Functional characterization of the bladder cancer marker, BLCA-4.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1158/1078-0432.CCR-0455-03

Identification of differentially expressed genes in hepatocellular carcinoma and metastatic liver tumors by oligonucleotide expression profiling

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-05-1142

Molecular biology of transitional cell carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-05-1142

Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-05-1142

Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinoma

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-05-1142

Potential utility of uroplakin III, thrombomodulin, high molecular weight cytokeratin, and cytokeratin 20 in noninvasive, invasive, and metastatic urothelial (transitional cell) carcinomas

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-05-1142

Regulation of androgen and vitamin d receptors by 1,25-dihydroxyvitamin D3 in human prostate epithelial and stromal cells

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-05-1142

VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-05-1142

Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-05-1142

Low interleukin-1alpha messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma.

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-05-1142

Nuclear structural proteins as biomarkers of cancer

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-05-1142

Role of thrombomodulin in cancer biology

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1158/0008-5472.CAN-05-1142

Identifiers

DOI

10.1158/0008-5472.CAN-05-1142

1 reference

20 September 2017

1 reference